dexmedetomidine has been researched along with Blood Poisoning in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (10.81) | 29.6817 |
2010's | 40 (54.05) | 24.3611 |
2020's | 26 (35.14) | 2.80 |
Authors | Studies |
---|---|
Liao, P; Liu, Z; Yang, B; Zeng, Y | 1 |
Deng, S; Gong, Y; Jin, P; Lenahan, C; Tan, J; Tian, M; Wang, K; Wang, W; Wang, Y; Wen, H; Zhao, F | 1 |
Hu, C; Hu, J; Li, J; Li, Y; Lian, Q; Ma, D; Wu, B | 1 |
Ambrósio, AM; de Olveira, CM; Fantoni, DT; Gonçalves, LA; Nagashima, JK; Pereira, MA; Talib, MS | 1 |
An, S; Chen, Z; Hu, H; Jin, Y; Li, L; Sha, T; Wu, F; Wu, J; Zeng, Z | 1 |
Auler-Jr, JOC; Carnicelli, P; Fantoni, DT; Ida, KK; Kahvegian, MAP; Monteiro Filho, A; Otsuki, DA; Rouby, JJ | 1 |
Anstey, C; Bailey, M; Fraser, JF; Moore, JPR; Murray, L; Reade, MC; Shehabi, Y; Singer, M | 1 |
Gong, C; Huang, Y; Liu, X; Tang, Y; Wang, D; Xiong, J; Zhang, Q | 1 |
Chen, L; Li, M; Li, Y; Liang, M; Lin, Y; Zeng, K | 1 |
Aidoni, Z; Foroulis, CN; Grosomanidis, V; Kazakos, G; Kotzampassi, K; Pourzitaki, C; Skourtis, C; Stamoula, E; Tsaousi, G; Vasilakos, DG | 1 |
Ao, X; Chen, DD; Deng, C; Li, JH; Liu, L; Wu, SZ; Zi, SF | 1 |
Bailey, SR; Bellomo, R; Evans, RG; Farmer, DGS; Hood, SG; Iguchi, N; Lankadeva, YR; Ma, S; May, CN | 1 |
Gao, M; Liu, D; Liu, Y; Song, F; Yang, P; Yu, T; Zhang, M; Zhang, X | 1 |
Liu, Y; Wang, C; Yu, Y; Zhang, J | 1 |
Chen, X; Gao, S; Ji, H; Yin, L | 1 |
Huang, Q; Kong, Q; Qiu, Z; Song, X; Wu, X; Xia, Z | 1 |
Chen, J; Qiu, J; Wang, R; Xie, Y | 1 |
Chen, P; Hu, B; Jiang, J; Levy, MM; Li, G; Qiu, Z; Zhang, Y | 1 |
Chen, X; Li, C; Liu, Y; Shao, Y; Wang, L; Zhao, W | 1 |
Hu, A; Li, Y; Lin, J; Wang, C; Xia, Z; Yang, CF; Yuan, W; Zhang, Z | 1 |
He, J; Kang, L; Ni, J; Wang, L; Yin, S; Zhong, Z | 1 |
Ding, L; Gao, X; Sheng, L; Yu, S | 1 |
Lu, Y; Zhu, S | 1 |
Aso, S; Fushimi, K; Matsui, H; Yasunaga, H | 1 |
Kawazoe, Y; Miyamoto, K; Morimoto, T; Ohta, Y; Yamamura, H | 1 |
Li, J; Mei, B; Zuo, Z | 1 |
Gao, Y; Han, QY; Huang, R; Kang, K; Kong, WL; Li, JY; Li, M; Li, NN; Liu, HT; Liu, RJ; Liu, YS; Qi, ZD; Wang, HL; Wang, SC; Yang, ZY; Yu, KJ; Zhang, WH; Zhang, X; Zhao, MY; Zheng, JB | 1 |
Bellomo, R; Deane, AM; Lankadeva, YR; May, CN; Plummer, MP; Shehabi, Y | 1 |
Anzueto, A; Bernard, GR; Brummel, NE; Bui, LN; Devlin, JW; Dittus, RS; Duprey, MS; Ely, EW; Girard, TD; Gropper, MA; Guntupalli, KK; Hoskins, AS; Hughes, CG; Jackson, JC; Kiehl, AL; Mailloux, PT; O'Neal, HR; Orun, OM; Pandharipande, PP; Patel, MB; Pun, BT; Raman, R; Sanders, RD; Snyder, A; Stashenko, GJ; Stollings, JL; Swan, JT | 1 |
Ma, S; Ma, X; Yang, H; Zhou, W | 1 |
Al-Bassam, W; Bellomo, R; James, A; Murfin, B; Shehabi, Y | 1 |
Beppu, S; Fuke, A; Hashimoto, A; Itoh, M; Katayama, Y; Kawazoe, Y; Koami, H; Miyamoto, K; Morimoto, T; Ohta, Y; Yamamoto, T; Yamamura, H | 1 |
Kuhn, SO; Rehberg, S; Scheer, CS | 1 |
Kawazoe, Y; Morimoto, T; Yamamura, H | 1 |
Amigoni, A; Blangetti, I; Casella, G; Chelazzi, C; Conti, G; Forfori, F; Garisto, C; Moltrasio, M; Mondardini, MC; Pasero, D; Principi, T; Ricci, Z; Romagnoli, S; Tarantino, F | 1 |
Cheng, Z; Feng, J; Li, A; Qian, H; Wu, Y; Xiao, H; Yan, F; Yang, Q; Zhang, X; Zhao, Z | 1 |
Gao, X; Hei, Z; Huang, P; Ji, H; Qiu, R; Sha, W; Wang, F; Yao, W; Yuan, D | 1 |
Cai, JQ; Cao, CC; Guo, RJ; Jia, L; Xu, WX; Xue, X; Yang, HJ; Zhao, W | 1 |
Gao, Y; Huang, R; Kang, K; Kong, WL; Liu, HT; Liu, RJ; Liu, YS; Qi, ZD; Qu, JD; Wang, HL; Wang, SC; Yu, KJ; Zhang, X; Zheng, JB | 1 |
Gromov, MS; Maslyakov, VV; Zabrodskii, PF | 1 |
Alam, A; Cui, J; Ma, D; Mu, DL; Sun, YB; Wang, DX; Wu, L; Zhang, W; Zhao, H | 1 |
Liang, FQ; Lin, Q; Xie, T; Zhang, JR | 1 |
Xu, P; Yang, W; Zhan, XH; Zhang, WQ; Zheng, P | 1 |
Aidoni, Z; Dardalas, I; Grosomanidis, V; Kouvelas, D; Malliou, F; Milonas, A; Papazisis, G; Pourzitaki, C; Rigopoulos, P; Stamoula, E; Tsaousi, G | 1 |
Chen, H; Jiang, XQ; Jin, YH; Li, ZT; Wu, F; Zhang, YY | 1 |
Bi, L; Jia, Z; Li, XK; Yang, SC | 1 |
Bao, H; Si, Y; Wang, X; Xu, L | 1 |
Akkuş, M; Altekin, E; Cilaker Mıcılı, S; Duru, S; Ergür, BU; Girgin, P; Gündüz, K; Güzeldağ, S; Koca, U; Olguner, ÇG; Taşdöğen, A | 1 |
Fleming, N; Ji, F; Li, Z; Liu, H; Nguyen, H; Shi, P; Young, N | 1 |
Huang, H; Huang, L; Li, X; Liu, Y; Lu, F; Wu, Y; Zhang, Y; Zhou, C; Zhu, Y | 1 |
Balarini, MM; Bouskela, E; Miranda, ML | 1 |
Li, H; Wang, Y; Wang, Z; Zhang, J; Zhou, G | 1 |
Li, ST; Wu, J | 1 |
Li, J; Li, X | 1 |
Chen, YJ; Gong, CL; Tan, F; Zhou, SL | 1 |
Chen, JH; Jin, SY; Lei, DX; Song, XR; Yu, GF; Zhang, WH; Zhou, SL | 1 |
Bahrami, A; Fakhri-Bafghi, MS; Hirbod-Mobarakeh, A; Keshavarz-Fathi, M; Nader, ND; Rezaei, N; Zamani, MM | 1 |
Gong, C; Jing, G; Liu, Z; Ning, Q; Wang, Q; Wang, Y; Zhang, Y; Zhao, W | 1 |
Rudiger, A; Singer, M | 1 |
Jiang, L; Li, ZJ; Ran, K; Wang, D; Zhang, SB; Zhang, Y | 1 |
Bissell, BD; Ferreira, JA | 1 |
Han, F; Liu, Z; Ning, Q; Sun, H; Wang, X; Yang, M; Zhang, J; Zhang, R; Zhang, X; Zhao, W | 1 |
Larson, JS; Patel, BM; Rady, MY | 1 |
DePriest, J; Gonzalez, L | 1 |
Gupta, A; Lee, D; Su, M | 1 |
Paciullo, C | 1 |
Ma, D; Maze, M; Qiao, H; Sanders, RD; Wu, X | 1 |
Memis, D; Sut, N; Tasdogan, M; Yuksel, M | 1 |
MacLaren, R | 1 |
Ely, EW; Girard, TD; Herr, DL; Maze, M; McGrane, S; Pandharipande, PP; Sanders, RD; Shintani, AK; Thompson, JL | 1 |
Memiş, D; Sezer, A; Süt, N; Usta, U | 1 |
Kress, JP | 1 |
Quintin, L | 1 |
Hekimoğlu, S; Memiş, D; Süt, N; Vatan, I; Yandim, T; Yüksel, M | 1 |
9 review(s) available for dexmedetomidine and Blood Poisoning
Article | Year |
---|---|
Efficacy and safety of dexmedetomidine in sepsis patients requiring mechanical ventilation: a systematic review and meta-analysis.
Topics: Dexmedetomidine; Humans; Intensive Care Units; Length of Stay; Respiration, Artificial; Sepsis | 2022 |
Effect of Dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis.
Topics: Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis; Treatment Outcome; Ventilator Weaning | 2020 |
Emerging benefits and drawbacks of α
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Clonidine; Critical Illness; Dexmedetomidine; Humans; Receptors, Adrenergic, alpha-2; Sepsis | 2021 |
Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients.
Topics: Acute Disease; Adult; Cardiac Surgical Procedures; Cerebrovascular Disorders; Child; Conscious Sedation; Critical Care; Critical Illness; Deep Sedation; Delirium; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Sepsis | 2018 |
Efficacy of dexmedetomidine for treatment of patients with sepsis: A meta-analysis of randomized controlled trials.
Topics: Aged; Dexmedetomidine; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 2019 |
Dexmedetomidine effects in different experimental sepsis in vivo models.
Topics: Animals; Dexmedetomidine; Disease Models, Animal; Humans; Organ Specificity; Sepsis | 2019 |
Dexmedetomidine May Produce Extra Protective Effects on Sepsis-induced Diaphragm Injury.
Topics: Dexmedetomidine; Diaphragm; Humans; Sepsis | 2015 |
Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: A systematic review.
Topics: Adolescent; Adult; Aged; Critical Care; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Randomized Controlled Trials as Topic; Sepsis; Treatment Outcome; Young Adult | 2016 |
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Catecholamines; Clonidine; Dexmedetomidine; Humans; Propanolamines; Sepsis; Shock, Septic; Stroke Volume; Sympathetic Nervous System; Sympatholytics; Tachycardia | 2018 |
9 trial(s) available for dexmedetomidine and Blood Poisoning
Article | Year |
---|---|
Microcirculation assessment of dexmedetomidine constant rate infusion during anesthesia of dogs with sepsis from pyometra: a randomized clinical study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Dexmedetomidine; Dog Diseases; Dogs; Female; Fentanyl; Isoflurane; Lactates; Microcirculation; Pyometra; Sepsis | 2022 |
Stress response during early sedation with dexmedetomidine compared with usual-care in ventilated critically ill patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Conscious Sedation; Critical Illness; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Propofol; Prospective Studies; Respiration, Artificial; Sepsis | 2022 |
Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial.
Topics: Aged; C-Reactive Protein; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Inflammation; Male; Middle Aged; Procalcitonin; Respiration, Artificial; Sepsis; Treatment Outcome | 2020 |
Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis.
Topics: Adult; Cognition; Conscious Sedation; Critical Illness; Dexmedetomidine; Double-Blind Method; Humans; Hypnotics and Sedatives; Kaplan-Meier Estimate; Propofol; Respiration, Artificial; Sepsis | 2021 |
Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Sepsis; Survival Analysis; Treatment Outcome; Ventilator Weaning | 2017 |
Perioperative dexmedetomidine improves outcomes of cardiac surgery.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Aged; Cardiac Surgical Procedures; Catecholamines; Delirium; Dexmedetomidine; Female; Heart Diseases; Hospital Mortality; Hospital Records; Humans; Hypnotics and Sedatives; Length of Stay; Male; Middle Aged; Myocardial Ischemia; Patient Readmission; Perioperative Care; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Stroke; Treatment Outcome | 2013 |
Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis.
Topics: Abdomen; Adrenergic alpha-Agonists; Adult; Aged; Dexmedetomidine; Female; Hospitals, University; Humans; Hypnotics and Sedatives; Inflammation; Infusions, Intravenous; Interleukin-1; Interleukin-6; Male; Middle Aged; Pilot Projects; Pressure; Propofol; Prospective Studies; Respiration, Artificial; Sepsis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Young Adult | 2009 |
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.
Topics: Adult; Aged; Coma; Delirium; Dexmedetomidine; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Intensive Care Units; Lorazepam; Male; Middle Aged; Outcome Assessment, Health Care; Respiration, Artificial; Sepsis | 2010 |
Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients.
Topics: Critical Illness; Dexmedetomidine; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Inflammation Mediators; Midazolam; Sepsis | 2007 |
56 other study(ies) available for dexmedetomidine and Blood Poisoning
Article | Year |
---|---|
Dexmedetomidine alleviates cognitive impairment by reducing blood-brain barrier interruption and neuroinflammation via regulating Th1/Th2/Th17 polarization in an experimental sepsis model of mice.
Topics: Animals; Blood-Brain Barrier; Cecum; Cognitive Dysfunction; Cytokines; Dexmedetomidine; Hippocampus; Inflammation; Male; Mice; Neuroinflammatory Diseases; Neuroprotective Agents; Sepsis; Th17 Cells | 2021 |
The role of the vagus nerve on dexmedetomidine promoting survival and lung protection in a sepsis model in rats.
Topics: Acetylcholine; Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Inflammatory Agents; Catecholamines; Dexmedetomidine; Interleukin-1beta; Lung; Protective Agents; Rats; Rats, Sprague-Dawley; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha; Vagotomy; Vagus Nerve | 2022 |
Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury.
Topics: Acute Kidney Injury; Cohort Studies; Critical Illness; Dexmedetomidine; Humans; Intensive Care Units; Retrospective Studies; Sepsis | 2022 |
Effects of dexmedetomidine on hemodynamic, oxygenation, microcirculation, and inflammatory markers in a porcine model of sepsis.
Topics: Animals; Dexmedetomidine; Hemodynamics; Microcirculation; Oxygen; Sepsis; Shock, Septic; Swine | 2022 |
Dexmedetomidine attenuates inflammation and organ injury partially by upregulating Nur77 in sepsis.
Topics: Animals; Cytokines; Dexmedetomidine; Inflammation; Lipopolysaccharides; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Sepsis; Tumor Necrosis Factor-alpha | 2023 |
Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats.
Topics: Acute Kidney Injury; Animals; Dexmedetomidine; Interleukin-6; Kidney; Leukocyte Elastase; Lipocalin-2; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2023 |
Circulatory effects of dexmedetomidine in early sepsis: a randomised controlled experimental study.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Escherichia coli Infections; Hemodynamics; Male; Sepsis; Swine; Swine Diseases | 2020 |
Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Dexmedetomidine; Down-Regulation; Interleukin-6; Lipopolysaccharides; Liver; Liver Diseases; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vagus Nerve | 2019 |
Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Cytokines; Dexmedetomidine; Drug Evaluation, Preclinical; Escherichia coli; Hemodynamics; Kidney; Norepinephrine; Oxygen; Sepsis; Sheep | 2019 |
Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line; Cytokines; Dexmedetomidine; Disease Models, Animal; Heart Diseases; Inflammation Mediators; Male; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Wistar; Sepsis; Signal Transduction; Ventricular Function, Left | 2019 |
The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Cytokines; Dexmedetomidine; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Protective Agents; Renal Insufficiency; Retinoblastoma-Binding Protein 2; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
Dexmedetomidine protects against sepsis‑associated encephalopathy through Hsp90/AKT signaling.
Topics: Animals; Cell Survival; Dexmedetomidine; HSP90 Heat-Shock Proteins; Male; Neurons; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sepsis; Sepsis-Associated Encephalopathy; Signal Transduction | 2019 |
Protective Effect of Dexmedetomidine on Acute Lung Injury via the Upregulation of Tumour Necrosis Factor-α-Induced Protein-8-like 2 in Septic Mice.
Topics: Acute Lung Injury; Administration, Intravenous; Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Gene Transfer Techniques; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Treatment Outcome; Up-Regulation | 2020 |
The Effects of Dexmedetomidine in a Rat Model of Sepsis-Induced Lung Injury are Mediated Through the Adenosine Monophosphate-Activated Protein Kinase (AMPK)/Silent Information Regulator 1 (SIRT1) Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Body Temperature; Cytokines; Dexmedetomidine; Disease Models, Animal; Inflammation Mediators; Lung; Lung Injury; Male; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Sirtuin 1; Survival Analysis | 2020 |
Dexmedetomidine alleviates lung injury in sepsis mice through regulating P38 MAPK signaling pathway.
Topics: Animals; Dexmedetomidine; Humans; Lung; Lung Injury; Mice; p38 Mitogen-Activated Protein Kinases; Sepsis; Signal Transduction | 2021 |
Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Ferroptosis; Heart; Heart Injuries; Male; Mice, Inbred C57BL; Myocardium; Sepsis | 2020 |
Effects of dexmedetomidine pretreatment on rats with sepsis-induced acute kidney injury and miR-146a expression.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Catalase; Creatinine; Dexmedetomidine; Heme Oxygenase (Decyclizing); Interleukin-1beta; Interleukin-6; Kidney; Lipopolysaccharides; Malondialdehyde; MicroRNAs; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sepsis; Superoxide Dismutase | 2020 |
miR-128-3p enhances the protective effect of dexmedetomidine on acute lung injury in septic mice by targeted inhibition of MAPK14.
Topics: Acute Lung Injury; Analgesics, Non-Narcotic; Animals; Dexmedetomidine; Male; Mice; MicroRNAs; Mitogen-Activated Protein Kinase 14; Sepsis | 2020 |
Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.
Topics: AlkB Homolog 5, RNA Demethylase; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Dexmedetomidine; Down-Regulation; Epigenesis, Genetic; Humans; Immunoprecipitation; In Vitro Techniques; Inflammation; Lipopolysaccharides; NF-kappa B; RNA, Long Noncoding; Sepsis; Signal Transduction | 2020 |
Dexmedetomidine and Mortality From Sepsis Requiring Mechanical Ventilation: A Japanese Nationwide Retrospective Cohort Study.
Topics: Adult; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Japan; Propofol; Respiration, Artificial; Retrospective Studies; Sepsis | 2021 |
Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor.
Topics: Animals; Brain Diseases; Dexmedetomidine; Inflammation; Male; Mice; Receptors, Adrenergic; Sepsis | 2021 |
Mechanisms of Renal-Splenic Axis Involvement in Acute Kidney Injury Mediated by the α7nAChR-NF-κB Signaling Pathway.
Topics: Acute Kidney Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Blotting, Western; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Random Allocation; Sepsis; Signal Transduction; Spleen; Splenectomy | 2021 |
[Effect of dexmedetomidine on expression of tight junction protein ZO-1 in kidney tissue of rats with acute kidney injury induced by sepsis].
Topics: Acute Kidney Injury; Animals; Dexmedetomidine; Kidney; Male; Rats; Rats, Sprague-Dawley; Sepsis; Zonula Occludens-1 Protein | 2020 |
Trials of dexmedetomidine sedation in ventilated critically ill septic patients: Challenges, limitations and opportunities.
Topics: Conscious Sedation; Critical Illness; Dexmedetomidine; Humans; Hypnotics and Sedatives; Sepsis | 2021 |
Dexmedetomidine in Patients With Sepsis Requiring Mechanical Ventilation.
Topics: Dexmedetomidine; Humans; Hypnotics and Sedatives; Respiration, Artificial; Sepsis | 2017 |
Dexmedetomidine in Patients With Sepsis Requiring Mechanical Ventilation-Reply.
Topics: Dexmedetomidine; Humans; Hypnotics and Sedatives; Respiration, Artificial; Sepsis | 2017 |
Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-κB pathway.
Topics: Animals; Anti-Inflammatory Agents; Dexmedetomidine; Disease Models, Animal; Drug Synergism; Gene Expression Regulation; Hippocampus; Injections, Intraperitoneal; Interleukin-6; Lipopolysaccharides; Neuroprotective Agents; NF-kappa B; Proline; Rats; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Thiocarbamates; Tumor Necrosis Factor-alpha | 2018 |
Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cecal Diseases; Cecum; Cytokines; Dexmedetomidine; Imidazoles; Inflammation; Kidney; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sepsis; Toll-Like Receptor 4 | 2018 |
Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system.
Topics: Acute Lung Injury; Animals; Apoptosis; Caspase 3; Dexmedetomidine; Immune System; Inflammation; Ki-67 Antigen; NF-kappa B; Protective Agents; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Taurine | 2018 |
Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
Topics: Acute Kidney Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Inflammation Mediators; Kidney Tubules; Lipopolysaccharides; Male; Mice, Inbred C57BL; Sepsis; Signal Transduction; Time Factors | 2018 |
Combined Effect of NF-κB Inhibitor and β2-Adrenoreceptor Agonist on Mouse Mortality and Blood Concentration of Proinflammatory Cytokines in Sepsis.
Topics: Adrenergic beta-Agonists; Animals; Cytokines; Dexmedetomidine; Female; Male; Mice; NF-kappa B; Nitriles; Sepsis; Signal Transduction; Sulfones | 2018 |
Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Astrocytes; Brain; Cytokines; Dexmedetomidine; Disease Models, Animal; Histones; Humans; Inflammasomes; Lipopolysaccharides; Male; Neuroglia; Neurons; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; PC12 Cells; Pyroptosis; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2019 |
Dexmedetomidine Attenuates Lung Injury by Promoting Mitochondrial Fission and Oxygen Consumption.
Topics: Acute Lung Injury; Animals; Apoptosis; Dexmedetomidine; Lung; Male; Mice; Mitochondria; Mitochondrial Dynamics; Mitochondrial Proteins; Oxidative Stress; Oxygen Consumption; Respiratory Function Tests; Sepsis | 2019 |
Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Topics: Acute Kidney Injury; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Humans; Kidney; Lipopolysaccharides; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Sepsis; Signal Transduction; Specific Pathogen-Free Organisms; Toll-Like Receptor 4 | 2019 |
Effects of dexmedetomidine on sepsis-induced liver injury in rats.
Topics: Animals; Dexmedetomidine; Disease Models, Animal; Lipopolysaccharides; Liver Diseases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Survival Analysis; Treatment Outcome | 2019 |
Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice.
Topics: Animals; Anti-Inflammatory Agents; Cecum; Cytokines; Dexmedetomidine; HMGB1 Protein; Ligation; Lung; Male; Mice; Mice, Inbred BALB C; RNA, Messenger; Sepsis | 2013 |
The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis.
Topics: Acute Kidney Injury; Acute Lung Injury; Acute-Phase Proteins; Animals; Apoptosis; Caspase 3; Cecum; Cell Count; Creatinine; Dexmedetomidine; Disease Models, Animal; DNA Fragmentation; Kidney; Lipocalin-2; Lipocalins; Lung; Macrophages, Alveolar; Male; Malondialdehyde; Proto-Oncogene Proteins; Rats; Rats, Wistar; Sepsis | 2013 |
Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway.
Topics: Animals; Blotting, Western; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Interleukin-6; Lung; NF-kappa B; Rats; Sepsis; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2013 |
Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blood Flow Velocity; Cricetinae; Dexmedetomidine; Male; Mesocricetus; Microcirculation; Sepsis | 2015 |
The effect of dexmedetomidine on inflammatory response of septic rats.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Inflammation; Interleukin-6; Ligation; Male; MAP Kinase Signaling System; Myeloid Differentiation Factor 88; NF-kappa B; Random Allocation; Rats, Sprague-Dawley; Sepsis; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
[Effect of dexmedetomidine on high-mobility group box 1 protein in rats with sepsis].
Topics: Animals; Dexmedetomidine; HMGB1 Protein; Lipopolysaccharides; Male; Rats; Rats, Wistar; Sepsis; Spleen; Tumor Necrosis Factor-alpha | 2015 |
[Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury].
Topics: Acute Kidney Injury; Animals; Dexmedetomidine; Inflammation; Interleukin-1beta; Kidney; Lipopolysaccharides; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sepsis; Superoxide Dismutase | 2015 |
Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Sepsis; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.
Topics: Adrenergic alpha-2 Receptor Agonists; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Bungarotoxins; Dexmedetomidine; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Decatecholaminisation during sepsis.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Catecholamines; Dexmedetomidine; Humans; Norepinephrine; Propanolamines; Sepsis | 2016 |
Dexmedetomidine may upregulate the expression of caveolin‑1 in lung tissues of rats with sepsis and improve the short‑term outcome.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Gas Analysis; Body Temperature; Caveolin 1; Dexmedetomidine; Disease Models, Animal; Hypnotics and Sedatives; Imidazoles; Lung; Male; Rats; Rats, Sprague-Dawley; Sepsis; Toll-Like Receptor 4; Up-Regulation | 2017 |
Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Diseases; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Lipopolysaccharides; Male; Malondialdehyde; Mice, Inbred BALB C; Neurodegenerative Diseases; Neuroimmunomodulation; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Reactive Oxygen Species; Sepsis; Tumor Necrosis Factor-alpha | 2017 |
Comparing dexmedetomidine with midazolam for sedation of patients in the ICU.
Topics: Adrenergic alpha-Agonists; Conscious Sedation; Critical Care; Dexmedetomidine; GABA Modulators; Humans; Hypnotics and Sedatives; Intensive Care Units; Midazolam; Respiration, Artificial; Sepsis | 2009 |
Comparing dexmedetomidine with midazolam for sedation of patients in the ICU.
Topics: Adrenergic alpha-Agonists; Conscious Sedation; Critical Care; Dexmedetomidine; GABA Modulators; Humans; Hypnotics and Sedatives; Intensive Care Units; Midazolam; Respiration, Artificial; Sepsis | 2009 |
Comparing dexmedetomidine with midazolam for sedation of patients in the ICU.
Topics: Adrenergic alpha-Agonists; Conscious Sedation; Critical Care; Dexmedetomidine; GABA Modulators; Humans; Hypnotics and Sedatives; Intensive Care Units; Midazolam; Respiration, Artificial; Sepsis; Substance Withdrawal Syndrome | 2009 |
Comparing dexmedetomidine with midazolam for sedation of patients in the ICU.
Topics: Adrenergic alpha-Agonists; Conscious Sedation; Critical Care; Dexmedetomidine; GABA Modulators; Humans; Hypnotics and Sedatives; Intensive Care Units; Midazolam; Respiration, Artificial; Sepsis | 2009 |
Sedation improves early outcome in severely septic Sprague Dawley rats.
Topics: Animals; Blotting, Western; Caspase 3; Dexmedetomidine; Hypnotics and Sedatives; Interleukin-6; Male; Midazolam; Rats; Rats, Sprague-Dawley; Sepsis; Severity of Illness Index; Signal Transduction; Spleen; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Immunosedation: a consideration for sepsis.
Topics: Dexmedetomidine; Humans; Hypnotics and Sedatives; Immune System; Midazolam; Sepsis | 2009 |
The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study.
Topics: Adrenergic alpha-Agonists; Animals; Dexmedetomidine; Endotoxemia; Endotoxins; Escherichia coli; Female; Inflammation; Lipopolysaccharides; Liver; Rats; Rats, Wistar; Sepsis | 2010 |
The complex interplay between delirium, sepsis and sedation.
Topics: Brain; Critical Illness; Delirium; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Lorazepam; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 2010 |
Alpha-2 adrenoceptor agonists and sepsis: improved survival?
Topics: Adrenergic alpha-2 Receptor Agonists; Dexmedetomidine; Fentanyl; Humans; Sepsis; Survival Analysis | 2010 |